Pharmaceutical Technology
FEBRUARY 15, 2023
Another area where we tend to see problems is in encapsulation efficiency,” says Andrew Kondratowicz, Bioassay Team Lead, Precision NanoSystems. The bioassays are the canary in the coal mine of how well your process development is going. Outlook The era of mRNA-based genomic medicines is on the horizon. Where is your payload?
pharmaphorum
AUGUST 5, 2021
It is a popular method in systems biology, requiring fewer compounds to be screened in bioassays, reducing time and cost. According to a 2021 publication “…recent advancements have made it possible to generate and analyse genome-wide PP I networks en masse by coupling Y2H with next-generation sequencing technology (NGS)”. .
pharmaphorum
SEPTEMBER 26, 2022
This year’s summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to develop resilient, long-lasting and robust analytical tools to enhance the safety, quality, and efficacy of gene therapy products.
Expert insights. Personalized for you.
130 
Let's personalize your content